PulseAugur
EN
LIVE 18:35:15
ENTITY Abbott

Abbott

PulseAugur coverage of Abbott — every cluster mentioning Abbott across labs, papers, and developer communities, ranked by signal.

Show in brief
Total · 30d
3
10 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
TIMELINE
  1. 2026-08-11 partnership Abbott and Google Health have partnered to integrate continuous glucose monitoring data into Google's health platforms. source
  2. 2026-05-17 product_launch Abbott launched its "Freedom 2 Save" program to help employees pay down student loans while contributing to their retirement. source
SENTIMENT · 30D

2 day(s) with sentiment data

RECENT · PAGE 1/1 · 10 TOTAL
  1. TOOL · CL_195173 ·

    Abbott and Google Health partner for AI-driven metabolic insights

    Abbott and Google Health are collaborating to integrate Abbott's Lingo continuous glucose monitor (CGM) data into the Google Health app. This partnership aims to provide users, including those without diabetes, with AI-…

  2. COMMENTARY · CL_192226 ·

    OpenAI eyes Texas for AI responsibility, Meta pushes open models amid criticism

    OpenAI has expressed interest in Texas as a potential leader in AI responsibility, though the state's current web infrastructure presents challenges. Meanwhile, Meta's Mark Zuckerberg criticized closed AI models while h…

  3. RESEARCH · CL_191987 ·

    Political identity fuels billions in consumer funding for tech startups

    Consumer funding is increasingly driven by political identity, with companies across the spectrum leveraging distrust in traditional institutions. Wearable tech companies like Oura and Whoop, and Bitcoin hardware wallet…

  4. COMMENTARY · CL_126286 ·

    Texas politician calls for ban on AI data centers, targets tax breaks

    A Texas politician is advocating for the prohibition of AI data centers in rural areas and neighborhoods, citing concerns about their impact and the tax breaks they receive. The politician, who is associated with Trump,…

  5. RESEARCH · CL_120366 ·

    Chinese artificial heart pump gains FDA approval for US clinical trials

    The BrioVAD, a Chinese-developed artificial heart pump, has received FDA approval for clinical trials in the United States. This marks the first time an active implantable medical device from China has been approved for…

  6. TOOL · CL_98773 ·

    Ultrahuman M2 Live offers accessible glucose tracking with AI insights

    Ultrahuman has launched its second-generation continuous glucose monitoring platform, the M2 Live, in the US. This new device utilizes Abbott's over-the-counter Lingo sensors, making metabolic tracking more accessible a…

  7. TOOL · CL_35522 ·

    Employers offer 401(k) matches to ease Gen X student debt

    Generation X faces significant financial strain due to high student loan debt, impacting their ability to save for retirement. Employers are increasingly offering benefits to alleviate this burden, such as matching 401(…

  8. RESEARCH · CL_30269 ·

    Hantavirus outbreak contained; quantum cancer imaging raises $55M

    Public health officials are monitoring a hantavirus outbreak that originated on a cruise ship, with no current signs of a widespread pandemic. Despite a high mortality rate for this strain, its spread requires close con…

  9. RESEARCH · CL_29940 ·

    NVision raises $38M for real-time cancer treatment imaging

    NVision, a startup specializing in cancer imaging, has secured $38 million in funding led by Abbott, with an additional $17 million venture loan. The company utilizes quantum technology to enhance MRI scans, allowing fo…

  10. RESEARCH · CL_26704 ·

    WHOOP raises $575M at $10.1B valuation, eyes health platform pivot

    WHOOP, a company known for its fitness wearables, has secured $575 million in Series G funding at a $10.1 billion valuation. This funding round, which included strategic investments from healthcare giants Abbott and May…